Whole-body Cx36-deficient mice develop beta cell destruction and hyperglycemia, whereas beta cell-specific transgenic Cx36 overexpression protects against single high-dose streptozotocin-induced diabetes and restores islet insulin contents in this model. Here, GJD2 is linked to Hyperglycemia.